Search Results

Sodium chloride 0.9% in multi injector devices

20 July 2023SPS PGD template for administering sodium chloride 0.9% intravenously for imaging investigations and procedures by registered Radiographers.

Omnipaque: informing intrathecal risk assessment

11 August 2022Omnipaque products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Ioversol (e.g. Optiray®) contrast agent

5 October 2021SPS PGD template for administering ioversol intravenously for imaging investigations and procedures by registered Radiographers.

Gadoxetate disodium (Primovist®) contrast agent

5 October 2021SPS PGD template for administering gadoxetate disodium intravenously for imaging investigations and procedures by registered Radiographers.

Gadoteridol (ProHance®) contrast agent

5 October 2021SPS PGD template for administering gadoteridol intravenously for imaging investigations and procedures by registered Radiographers.

Gadobenate dimeglumine (MultiHance®) contrast agent

5 October 2021SPS PGD template for administering gadobenate dimeglumine intravenously for imaging investigations and procedures by registered Radiographers.

Gadoteric acid meglumine contrast agent

5 October 2021SPS PGD template for administering gadoteric acid meglumine intravenously for imaging investigations and procedures by registered Radiographers.

Gadobutrol (Gadovist®) contrast agent

5 October 2021SPS PGD template for administering gadobutrol intravenously for imaging investigations and procedures by registered Radiographers.

Iodixanol (e.g. Visipaque®) contrast agent

5 October 2021SPS PGD template for administering iodixanol intravenously for imaging investigations and procedures by registered Radiographers.

Iohexol (e.g. Omnipaque®) contrast agent

5 October 2021SPS PGD template for administering iohexol intravenously for imaging investigations and procedures by registered Radiographers.

SPS - Specialist Pharmacy Service

NHS

Radiology, Guidance

12 results